9th Annual European Drug Safety Pharma & Biotech Conference
World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under the Why Summits Future of Pharmacovigilance World Tour
This is not just another Drug safety conference. This is a conference which tells you a STORY. One personal experience followed by another, a storyline of exceptional people who happen to choose Drug Safety and Pharmacovigilance as their way to bring needed medicines and protect those who are the most vulnerable, and to improve the health of millions of people on our planet. You will hear experts talk about the current issues in this ever-evolving industry. The best practice case studies on how to integrate new, disruptive technology into the rather rigid processes of PV organization and how it evolves to stay compliant. But how to do this with the more and more restrictive budget? How to prioritize, what methodologies to use for advanced therapies? What is the next evolution step in signal detection noise clearance? Are A.I.-based tools to become our colleagues, helpmates, or our replacement? Nonetheless, each company, department, and project starts with people. But how to build a winning cross-functional team and what kind of workforce is necessary for a drug safety department of the future? What kind of skills to expect from millennials and gen-z entering the industry and why do we need veterans in the industry as well? Challenges with innovations, outsourcing, everchanging regulatory landscape, harmonization, teaching other departments on how to use RWE data, and engaging the more and more aware public. All these topics we address, are conveyed having our mission in our mind, bringing medicines and new therapeutic indications to patients, faster, safer, and more sustainably. Our visionary keynote presentations and best practice case studies will complement engaging panel discussions with different speakers to better understand Pharmacovigilance challenges and solutions from different perspectives, with unique views coming from some of the most experienced and passionate professionals. Our conference will feature numerous assisted formal and informal networking, matchmaking, and breakout sessions to create those critical business friendships that will bring fruitful cooperation and fill that missing piece in our common mission to improve drug safety and quality of life for all.
KEY TOPICS
Pharmacovigilance of advanced therapies
Stepping up the global game in PV reporting strategies
Outcomes of rising public awareness: social media and mobile apps in pharmacovigilance E2B(R3) implementation, are you truly compliant? EudraVigilance and FDA case studies
Soft skills in world of regulations: interactive workshop
Creating a talent pool for the next generation of pharmacovigilance- is your job at peril? EMA and NCAs guidance during COVID-19 pandemics and vision in the post-covid era
Natural Language Processing as a necessary tool in PV reporting
Navigating PV disruption and skills required to survive
Struggle to minimize costs with new technology: transfer smarter, not costlier
The vision of outsourcing in the pharma industry: current and future trends
Drug safety in oncology: consequences of accelerated approvals in Europe
An innovative roadmap to the adoption of marketed pharmacovigilance automation and Artificial Intelligence (AI) with a focus on efficiency ROI
PV audit storytelling session – Inspection insights from a global perspective
Enhancing PV compliance in a joint partnership for a product marketed in differently regulated markets
Who will attend
25% Industry consultants, Academia & Solutions and Software providers
75% Big & SME Pharma and Biotech companies
“Great dialogue on key issues. Everyone shared truthful insight and did not hold back, even on negative experiences.”
Sameer Thapar
Assistant Professor & Advisor, Drug Safety and Pharmacovigilance, Rutgers University
“High-quality speakers and attendees, a great mix between healthcare providers, life science companies, providers of digital health & AI solutions, and investors.”
John Mulcahy
CEO, HealthGenuity
“Unlike some other similar events, I found relevance in every session within your conference. The content was neither too simplistic nor too advanced. The participants and presenters provided a diverse view of the issues that are present for most in this industry.”
Christine Clearwater
Manager, Safety Operations and Vendor Management, Baxter, Global Patient Safety
“Loved it. It was very practical and provided valuable insight into practical methods that are actionable for patient safety.”
Daniel Naranjo
Global Safety Lead, Global Patient Safety Evaluation, Takeda